Skip to content
Search

Latest Stories

Submit Guest Post

Coronavirus impact: Karan Johar’s Takht and Dostana 2 to be shelved?

The coronavirus pandemic has engulfed the entire world, claiming thousands of lives all across the globe. With the pandemic continuing to spiral out of control, the global economy has started crippling in a big way. Bollywood, the biggest film producing industry in the world, has not been spared either.

The release of several big-ticket films has been deferred over the past few days. A number of events meant to launch the trailers of upcoming movies and announce new projects have been cancelled. Not just Bollywood, Indian television industry and the webspace are also suffering in the current situation.


Now, rumour has it that Dharma Productions’ two upcoming projects may be dropped considering the ongoing situation. We are talking about period drama Takht and comic-caper Dostana 2. While Takht features Ranveer Singh, Kareena Kapoor Khan, Alia Bhatt, Vicky Kaushal, Bhumi Pednekar, Janhvi Kapoor and Anil Kapoor in lead roles, Dostana 2, a sequel to Dostana (2008) stars Kartik Aaryan, Janhvi Kapoor and Lakshya in central characters. Both films may be shelved because of the Coronavirus crisis.

Takht was already an endangered project, what with controversies regarding its content and the scriptwriter being accused of a communal tweet. Still, Karan may have gone ahead with it. But now with the viral situation, Takht is strictly a no-can-do project for all concerned,” a well-placed source informs an entertainment portal.

Recently, Dharma Productions’ head honcho Karan Johar released a statement announcing the lockdown of his production house until further notice. “In view of the epidemic spread of the COVID-19 virus throughout the world including India, we at Dharma Productions have suspended all administrative and production work until further notice,” read the statement.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

Weekly insulin jab

A weekly insulin jab could reduce the burden of daily injections for some people with type 2 diabetes

iStock

From 365 injections to 52: New weekly insulin jab could make life easier for patients

  • The treatment could reduce insulin injections from 365 a year to just 52.
  • NICE has recommended the weekly treatment, but it still needs MHRA approval.
  • People who rely on carers or struggle with daily injections could benefit most.

For some people with type 2 diabetes, managing their condition could soon involve one insulin injection a week instead of one every day.

The National Institute for Health and Care Excellence (NICE) has recommended insulin efsitora alfa, also known as Onswik and made by Eli Lilly, in its final draft guidance. If approved by the medicines regulator and subsequently rolled out on the NHS, the treatment could reduce the number of annual insulin injections from 365 to 52.

Keep ReadingShow less